GBP/USD1.2734 0.0042|EUR/USD1.0851 0.0019|GBP/EUR1.1736 0.0028|DXY104.21 0.18|FTSE 1008,224.31 18.42|GBP/USD1.2734 0.0042|EUR/USD1.0851 0.0019|GBP/EUR1.1736 0.0028|DXY104.21 0.18|FTSE 1008,224.31 18.42|
Regulatory

ANVISA Warns About AI-Generated Fake Endorsements Used to Promote Medicines and Dietary Supplements

News · July 22, 2026·1 min read
ANVISA warning on AI-generated fake medical endorsements

The Brazilian Health Regulatory Agency (ANVISA) has issued a public warning regarding the growing use of artificial intelligence to create fake videos and images of healthcare professionals and public figures for the promotion of medicines and dietary supplements on social media.

According to the agency, these AI-generated contents can mislead consumers, spread false health information, and encourage the inappropriate use of products, posing potential risks to public health.

The Growing Challenge of AI-Generated Misinformation

Recent advances in generative AI have made it possible to produce highly realistic videos and voice recordings that appear to feature physicians, researchers, or celebrities endorsing products they have never recommended.

These deceptive practices are increasingly being used to market dietary supplements and products with unsubstantiated health claims, making it more difficult for consumers to distinguish legitimate medical information from fabricated content.

ANVISA’s Position

ANVISA emphasizes that dietary supplements cannot claim to prevent, treat, or cure diseases unless they are properly regulated as medicines and supported by scientific evidence.

The agency also encourages consumers to verify health-related information through official sources and to be cautious when encountering extraordinary claims promoted on social media.

The Advanced Life Sciences Perspective

Artificial intelligence has enormous potential to transform the Life Sciences industry by improving productivity, supporting regulatory compliance, optimizing laboratory operations, and accelerating innovation.

However, like any powerful technology, AI must be used responsibly, ethically, and transparently.

The use of AI to fabricate medical endorsements or promote misleading health claims undermines public trust and may expose patients and consumers to unnecessary risks.

At Advanced Life Sciences, we believe that innovation should always be accompanied by scientific integrity, regulatory compliance, and a strong commitment to protecting public health.

Source: ANVISA public warning and related media reports published on July 22, 2026.
ANVISAArtificial IntelligenceDeepfakePublic HealthRegulatory Compliance